Rana Atique Anwer, Sajid Ghafor, Huma Ahmad. “Neoadjuvant Docetaxel Plus Carboplatin Versus Epirubicin Plus Cyclophosphamide Followed by Docetaxel in Triple-Negative, Early-Stage Breast Cancer”. Pakistan Journal of Medical & Health Sciences, vol. 16, no. 08, Sept. 2022, p. 356, doi:10.53350/pjmhs22168356.